Skip to main content
Premium Trial:

Request an Annual Quote

ChomiX Biotech Completes Multimillion-Dollar Financing

NEW YORK – Drug development firm ChomiX Biotech said Monday that it has raised multiple millions of dollars in financing.

The Nanjing, China-based company said it will use the funds to further develop its chemoproteomics platforms, expand its covalent compound libraries, and start screening projects against several traditionally undruggable targets.

Investors in the round included TigerYeah Capital, Tsinghua Innovation Ventures, and Morning Spring Venture.

According to ChomiX, its DIA-ABPP chemoproteomics platform allows for drug screening experiments in living cells, enabling the discovery of new binding pockets and ligands for endogenous proteins. The platform covers more than 10,000 proteins and 40,000 binding sites.

Its TED-ChomiX platform identifies interactions between proteins and biologically active molecules in disease-related cells or tissues, aiding in mechanism-of-action studies and off-target profiling.

"This financing, along with a series pre-A announced last year, will significantly strengthen our capacity," Nan Chen, CEO and cofounder of ChomiX, said in a statement. "By leveraging these cutting-edge chemical proteomics technologies, we could provide more solutions for undruggable targets, which will contribute to the development of more drugs that benefit patients."

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.